AmeriCann (ACAN) Stock Price, News & Analysis

Company Overview

AmeriCann, Inc. is a vertically integrated cannabis services and development company focused on cultivating, processing, and managing cannabis operations across the United States. Headquartered in Chicago, Illinois, the company specializes in end-to-end solutions for cannabis license holders and real estate owners, offering expertise in cultivation facility design, build-out, operational management, and regulatory compliance. AmeriCann’s model emphasizes scalable infrastructure, quality controls, and sustainable cultivation practices to meet the evolving needs of state-licensed operators.

The company’s core offerings include cultivation consulting, greenhouse and indoor cultivation design, extraction and processing facility development, and dispensing center support. AmeriCann works closely with licensed operators to optimize growing environments, implement best-in-class processing protocols, and ensure adherence to state and local regulations. In addition to facility development, its services extend to supply chain optimization, product formulation, and packaging compliance to support a broad range of adult-use and medical cannabis products.

AmeriCann has established partnerships and project engagements in multiple regulated markets, including Illinois, Massachusetts, Oklahoma, and Florida. Through joint ventures and management agreements, the company assists licensees in navigating complex regulatory frameworks while accelerating time-to-market for new cultivation sites and product lines. Its geographic reach and diversified project pipeline position AmeriCann to capitalize on the continued expansion of legal cannabis programs across the country.

Since its inception in 2014, AmeriCann has been led by a management team with deep experience in horticulture, engineering, biopharmaceuticals, and regulatory affairs. The leadership group’s combined expertise in large-scale agricultural systems, quality assurance, and regulatory strategy underpins the company’s commitment to operational excellence and product consistency. AmeriCann’s emphasis on health, safety, and environmental stewardship aims to set industry standards for compliance and sustainable growth in the dynamic cannabis market.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 27,675 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ACAN Stock Analysis - Frequently Asked Questions

How do I buy shares of AmeriCann?

Shares of ACAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of AmeriCann own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AmeriCann investors own include Canopy Growth (CGC), Fulcrum Therapeutics (FULC), GE Aerospace (GE), Innovative Industrial Properties (IIPR), Kushco (KSHB), MedMen Enterprises (MMNFF) and NVIDIA (NVDA).

Company Calendar

• Today: 7/18/2025
• Next Earnings (Estimated): 8/11/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Real Estate
• Industry: Real Estate Services
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:ACAN
• CIK: 1508348
• Web: americann.co
• Phone: (303) 862-9000
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A